Monitoring of female human papillomavirus carriers with background and precancer diseases of the cervix uteri
https://doi.org/10.17650/1994-4098-2010-0-1-55-58
Abstract
In women with background diseases of the cervix uteri, human papillomavirus (HPV) types 16 and 18 infection was found in 26.9% of cases, while in those with varying cervical intraepithelial neoplasia, it was in 68.5% of cases, i.e. 2.5 times higher, mainly at the age of 25 to 30 years. Polymerase chain reaction serum assays for HPV infection were negative in 99.9% of cases.
After diathermoelectronization of the cervix uteri, HPV was identified in 28.6% of the female virus carriers with background diseases and in 49.9% of the women with varying dysplasia, i.e. half the female virus carriers in this group continued to have the earlier iden- tified HPV types 16 and 18.
About the Authors
N. N. Zakhirova
Tashkent Medical Academy, Tashkent City Cancer Dispensary, Institute of Plant Genetics and Experimental Biology, Academy of Sciences of the Republic of Uzbekistan
Russian Federation
Russian Federation
N. E. Atakhanova
Tashkent Medical Academy, Tashkent City Cancer Dispensary, Institute of Plant Genetics and Experimental Biology, Academy of Sciences of the Republic of Uzbekistan
Russian Federation
Russian Federation
B. K. Irisbayev
Tashkent Medical Academy, Tashkent City Cancer Dispensary, Institute of Plant Genetics and Experimental Biology, Academy of Sciences of the Republic of Uzbekistan
Russian Federation
Russian Federation
N. N. Gapparova
Tashkent Medical Academy, Tashkent City Cancer Dispensary, Institute of Plant Genetics and Experimental Biology, Academy of Sciences of the Republic of Uzbekistan
Russian Federation
Russian Federation
References
1. Новик В.И. Эпидемиология рака шейки матки, факторы риска, скрининг. Практ онкол 2002;3(3): 156—65.
2. Роговская С.И., Прилепская В.Н., Межевитинова Е.А. и др. Папилломавирусная инфекция гениталий у женщин. Вестн дерматол венерол 1998;(6):48—51.
3. Александрова Ю.Н., Лыщев А.А., Сафронникова Н.Р. и др. Папилломавирусная инфекция
4. у здоровых женщин Санкт- Петербурга. Вопр онкол 2000;46(2):175—9.
5. Волков В.Г., Захарова Т.В. Роль вируса папилломы человека в возникновении рака шейки матки. Вестн нов мед технол 1999;(2):85—8.
6. Филатенков А.Г., Богатырева И.И., Самсонов В.А. и др. Особенности клиники и лечения урогенитальных поражений ВПЧ у женщин на фоне других заболеваний, передаваемых половым путем. Вестн дерматол венерол 1997;(3):73—6.
7. Голованова В.А., Новик В.И., Гуркин Ю.А. Частота и факторы риска папилломавирусной инфекции
8. и дисплазии эпителия шейки матки у сексуально активных девушек- подростков. Вопр онкол 1999;(6): 623—6.
9. Cecchini S., Grazzini G., Iossa A. et al. Subclinical vulvar papillomavirus infection. J Reprod Med 1991;36(2):143—6.
10. Хмельницкий О.К. Цитологическая и гистологическая диагностика заболеваний шейки
11. и тела матки. — СПб., 1999.
12. Дубенский В.В. Урогенитальная папилломавирусная инфекция (обзор). Рос журн кож венер бол 2000;(5):50—5.
13. Abadi M.A., Ho G.Y., Burk R.D. et al. Stringent criteria for histological diagnosis of koilocytosis fail to eliminate overdiagnosis of human papillomavirus infection and cervical intraepithelial neo- plasia grade 1. Hum Pathol 1998;29(1):54—9.
14. Kusera E., Sluitz G., Czervenka K. Is high risk HPV-infection associated with cervical intraepithelium neoplasia? Eur J Obstet Gynaecol Reprod Biol 2001;100(1):72—6.
15. Вишневский А.С., Сафронникова Н.Р. Дискуссионные вопросы лечения папилломавирусной инфекции шейки матки. Практ онкол 2002;3(3):166—72.
Review
For citations:
Zakhirova N.N., Atakhanova N.E., Irisbayev B.K., Gapparova N.N. Monitoring of female human papillomavirus carriers with background and precancer diseases of the cervix uteri. Tumors of female reproductive system. 2010;(1):55-58. (In Russ.) https://doi.org/10.17650/1994-4098-2010-0-1-55-58
Views:
590
Email this article 